Deepak Nitrite Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 19, 2026

Key Highlights

The Latest Trading Price of Deepak Nitrite Ltd is ₹ 1383 as of 19 Mar 15:30 . The P/E Ratio of Deepak Nitrite Ltd changed from 29.1 on March 2021 to 38.8 on March 2025 . This represents a CAGR of 5.92% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of Deepak Nitrite Ltd changed from ₹ 22599 crore on March 2021 to ₹ 27043 crore on March 2025 . This represents a CAGR of 3.66% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of Deepak Nitrite Ltd for the Dec '25 is ₹ 1983 crore as compare to the Sep '25 revenue of ₹ 1921 crore. This represent the growth of 3.21% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Deepak Nitrite Ltd for the Dec '25 is ₹ 206.56 crore as compare to the Sep '25 ebitda of ₹ 224.22 crore. This represent the decline of -7.88% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Deepak Nitrite Ltd changed from ₹ 202.53 crore to ₹ 99.82 crore over 7 quarters. This represents a CAGR of -33.26% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of Deepak Nitrite Ltd changed from 21.15 % on March 2021 to 37.01 % on March 2025 . This represents a CAGR of 11.84% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About Deepak Nitrite Ltd

Deepak Nitrite Limited (DNL) is a prominent chemical manufacturing company.
The Company manufactures Advanced Intermediates.
It has a diversified portfolio of chemical intermediates that cater to various end-user industries and falls under Strategic Business Units (SBUs) of Basic Chemicals (BC), Fine and Speciality Chemicals (FSC) and Performance Products (PP).
Company is having two state-of-the-art pilot facilities, one each at Roha, Maharashtra and Nandesari, Gujarat.
The pilot plants act as link between R&D and commercial production of various intermediates used in Agrochemicals, Dyes, Pharmaceuticals etc. Deepak Nitrite Limited was incorporated in June, 1970.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of Deepak Nitrite Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, Deepak Nitrite Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of Deepak Nitrite Ltd is 18,863 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,700 Cr

What are the key factors driving the stock performance of Deepak Nitrite Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of Deepak Nitrite Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Deepak Nitrite Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 19, 2026, the Deepak Nitrite Ltd stock price is INR ₹1383.05. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1154.4.

How do dividend payouts of Deepak Nitrite Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of Deepak Nitrite Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.